Congressman Gonzalez Applauds New Medicare Drug Pricing Rule Aimed at Lowering Prescription Drug Prices

Translate to Spanish or other 102 languages!

The new rule includes language from Congressman Gonzalez’s PHAIR Pricing Act

Mega Doctor News

- Advertisement -

WASHINGTON – Congressman Vicente Gonzalez (TX-15) today announced that the Centers for Medicare and Medicaid Services has issued a proposed rule that lowers prescription drug costs and increases transparency surrounding Medicare Parts C and D.

In May 2018, Congressmen Gonzalez and Doug Collins (GA-09) introduced the bipartisan H.R. 5958, the PHAIR Pricing Act of 2018, to lower drug costs to Medicare recipients at the point of sale. The new rule includes language from this bill.

“Medicare recipients deserve transparency,” Congressman Gonzalez said. “Prescription drug prices should not be decided behind a curtain and the final cost should not be equal to almost 50 percent above the negotiated price. The road to fixing America’s prescription drug market may be long, but I commend the Centers for Medicare and Medicaid Services for taking this important step.”

- Advertisement -

Congressman Gonzalez has pledged to make it his mission in Congress to make affordable, accessible healthcare and prescription drugs readily available to Central and South Texans.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Starr County Healthcare Workforce Gets $100K Boost via New Internship Fund

Workforce Solutions (WFS) announced the launch of the $100,000 Healthcare Internship Fund, an innovative workforce development initiative designed to create structured, paid internship opportunities for 91 students pursuing high-demand healthcare careers across the region.

4th of July Fireworks Safety Guide for Parents

As families gear up for backyard barbecues, fireworks displays and other Fourth of July celebrations, safety should be part of the preparation.

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.
- Advertisement -